Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical ...

Plus, Nimy gets set to cash-in on US gallium demand and Orion fires-up on BHP backing and project funding talk.

The company has garnered FDA fast-track status and will soon start a controlled trial of its oncolytic virus with standard therapy.

Q4 2025 Earnings Call February 5, 2026 8:00 AM ESTCompany ParticipantsCarl Arnet - Chief Executive OfficerBrice Morlot - ...

Conservationists and many First Nations are celebrating a Federal Court of Appeal decision that upholds the closure of salmon ...

More than two years after it was filed, one of Oklahoma’s lawsuits against natural gas marketers for massive charges during a ...

Incubated by Flagship Pioneering, Generate applies AI to teasing out the three-dimensional structure of human proteins, ...

The new Spurlino Foundation Discovery Center opened in January 2026 at Audubon’s Corkscrew Swamp Sanctuary. The ...

For much of the past decade, India’s role in global pharmaceutical outsourcing was defined narrowly, efficient execution, strong chemistry and cost advantage. That narrative is now being rewritten.

“The next phase of corporate bond market development depends on issuers, investors, intermediaries, stock exchanges and ...

NorthStrive Biosciences Inc. ("NorthStrive Biosciences"), a subsidiary of PMGC Holdings Inc. (NASDAQ:ELAB) ("PMGC"), today announced a progress ...

BFSI brands in 2026 are grappling with a digital-first and sceptical audience. In this story, BFSI leaders break down the ...